Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$226M |
| 2 |
FedEx
FDX
|
+$181M |
| 3 |
Intel
INTC
|
+$173M |
| 4 |
Restaurant Brands International
QSR
|
+$169M |
| 5 |
Mohawk Industries
MHK
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$335M |
| 2 |
Viatris
VTRS
|
+$233M |
| 3 |
Merck
MRK
|
+$230M |
| 4 |
Pfizer
PFE
|
+$216M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.32% |
| 2 | Energy | 11.41% |
| 3 | Miscellaneous | 10.53% |
| 4 | Healthcare | 9.72% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.07B
| $33K | ﹤0.01% |
1,200
| – | – |
2014 Q4
1 quarter
|
|
|
CAF
3077
Morgan Stanley China A Share Fund
CAF
$235M
| $33K | ﹤0.01% |
1,000
| – | – |
2014 Q1
4 quarters
|
|
3078
BlackRock Debt Strategies Fund
DSU
$578M
| $33K | ﹤0.01% |
2,937
| – | – |
2013 Q2
7 quarters
|
|
3079
Groupon
GRPN
$794M
| $33K | ﹤0.01% |
232
+189
| +440% | +$29K |
2014 Q4
1 quarter
|
|
|
KE
3080
Kimball Electronics
KE
$679M
| $33K | ﹤0.01% |
+2,311
| New | +$27.7K |
2015 Q1
0 quarters
|
|
3081
NBT Bancorp
NBTB
$2.64B
| $33K | ﹤0.01% |
1,290
| – | – |
2013 Q2
7 quarters
|
|
|
RMAX
3082
DELISTED
RE/MAX Holdings
RMAX
| $33K | ﹤0.01% |
1,000
| – | – |
2013 Q4
5 quarters
|
|
3083
Boston Beer
SAM
$1.71B
| $33K | ﹤0.01% |
123
-143
| -54% | -$41.4K |
2013 Q2
7 quarters
|
|
3084
Scholastic
SCHL
$660M
| $33K | ﹤0.01% |
809
+5
| +0.6% | +$185 |
2013 Q2
7 quarters
|
|
3085
SunCoke Energy
SXC
$827M
| $33K | ﹤0.01% |
2,200
-742
| -25% | -$12.7K |
2013 Q2
7 quarters
|
|
|
CLVS
3086
DELISTED
Clovis Oncology, Inc.
CLVS
| $33K | ﹤0.01% |
+445
| New | +$31.4K |
2015 Q1
0 quarters
|
|
|
FMO
3087
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
| $33K | ﹤0.01% |
254
+60
| +31% | +$7.35K |
2013 Q2
7 quarters
|
|
|
NTRI
3088
DELISTED
NutriSystem, Inc.
NTRI
| $33K | ﹤0.01% |
1,666
+249
| +18% | +$4.62K |
2013 Q4
5 quarters
|
|
|
OCRX
3089
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $33K | ﹤0.01% |
7,000
-3,000
| -30% | -$17.3K |
2014 Q4
1 quarter
|
|
|
IGTE
3090
DELISTED
IGATE CORPORATION
IGTE
| $33K | ﹤0.01% |
764
| – | – |
2013 Q2
7 quarters
|
|
|
BOI
3091
DELISTED
Brookfield Mtge Opportunity Fd
BOI
| $33K | ﹤0.01% |
2,000
-500
| -20% | -$8.22K |
2014 Q4
1 quarter
|
|
3092
Dorman Products
DORM
$3.65B
| $32K | ﹤0.01% |
657
-1,101
| -63% | -$51.8K |
2013 Q2
7 quarters
|
|
3093
Neurogene
NGNE
$531M
| $32K | ﹤0.01% |
+195
| New | +$39.6K |
2015 Q1
0 quarters
|
|
|
PPLT
3094
abrdn Physical Platinum Shares ETF
PPLT
$2.08B
| $32K | ﹤0.01% |
2,850
+2,500
| +714% | +$28.9K |
2013 Q2
7 quarters
|
|
3095
TRI-Continental Corp
TY
$1.83B
| $32K | ﹤0.01% |
1,486
| – | – |
2013 Q2
7 quarters
|
|
3096
Wayfair
W
$13.9B
| $32K | ﹤0.01% |
+1,000
| New | +$24.9K |
2015 Q1
0 quarters
|
|
|
ASXC
3097
DELISTED
Asensus Surgical, Inc.
ASXC
| $32K | ﹤0.01% |
826
+810
| +5,063% | +$30.6K |
2014 Q4
1 quarter
|
|
|
ARGO
3098
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $32K | ﹤0.01% |
805
-3,918
| -83% | -$152K |
2014 Q2
3 quarters
|
|
|
JMF
3099
DELISTED
NUVEEN ENERGY MLP TOTAL RETURN FUND
JMF
| $32K | ﹤0.01% |
1,765
| – | – |
2013 Q2
7 quarters
|
|
|
FIGY
3100
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
| $32K | ﹤0.01% |
269
-35
| -12% | -$4.2K |
2014 Q3
2 quarters
|
|
Similar funds
Bank of Montreal's Q1 2015 Portfolio in Review
As of Q1 2015, Bank of Montreal held 4,475 positions worth $86.3B, down 2.1% from $88.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal's Q1 2015 filing shows 379 new, 1,429 increased, 1,543 reduced and 407 closed positions. Its largest new stake was Walgreens Boots Alliance: 2,840,150 shares worth $241M. The largest sale was Apple, an estimated $335M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q1 2015 buy was Walgreens Boots Alliance: 2,840,150 shares worth $241M.
- Bank of Montreal added most to FedEx in Q1 2015, an estimated $181M increase.
- Bank of Montreal's biggest Q1 2015 reduction was Apple, cutting an estimated $335M.
- Bank of Montreal fully exited Allergan Inc in Q1 2015, selling an estimated $54.9M.
- Bank of Montreal's ten largest holdings make up 23% of its $86.3B portfolio in Q1 2015.
- Bank of Montreal opened 379 new positions and closed 407 in Q1 2015.
- Bank of Montreal's portfolio value fell 2.1% quarter-over-quarter to $86.3B.
Based on Bank of Montreal's 13F filing for Q1 2015, filed 13 May 2015.